Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study

Publisher： Karger

E-ISSN： 1421-9670|45|5|452-459

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.45, Iss.5, 2017-05, pp. : 452-459

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia

By  

Nephron, Vol. 130, Iss. 4, 2015-07 ,pp. : 229-238

Karger

Access to resources Recommend Favorite

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study

By  

Kidney and Blood Pressure Research, Vol. 42, Iss. 1, 2017-03 ,pp. : 33-42

Karger

Access to resources Recommend Favorite

Isonatric Dialysis Biofeedback in Hemodiafiltration with Online Regeneration of Ultrafiltrate in Hypertensive Hemodialysis Patients: A Randomized Controlled Study

By  

Blood Purification, Vol. 41, Iss. 1-3, 2015-11 ,pp. : 87-93

Karger

Access to resources Recommend Favorite

A Double-Blind, Placebo Controlled, Randomized Phase 1 Cross-Over Study with ALLN-177, an Orally Administered Oxalate Degrading Enzyme

By  

American Journal of Nephrology, Vol. 44, Iss. 2, 2016-08 ,pp. : 150-158

Karger

Access to resources Recommend Favorite

Aliskiren, a Direct Renin Inhibitor, Improves Vascular Endothelial Function in Patients on Hemodialysis Independent of Antihypertensive Effect ∼ a Pilot Study∼

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 2-3, 2013-05 ,pp. : 190-198

Karger

Access to resources Recommend Favorite